Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Inexpensive Compact Microscope Diagnoses Tuberculosis

By LabMedica International staff writers
Posted on 17 Aug 2010
A portable, battery-operated fluorescence microscope can easily be used to diagnose tuberculosis (TB). More...


The microscope has been tested on samples from patients with TB and performed as well as a reference-standard fluorescence microscope. The microscope weighs 1.1 kg and is inexpensive, transportable, and flexible. It could be used in clinics in developing countries that have limited access to laboratory equipment and may lack electricity.

The Global Focus microscope uses a battery-operated LED-based flashlight as the light source and achieves a maximum spatial resolution of 0.8 µm at 1000× magnification in fluorescence mode. The resolution of the microscope is 3.2 times larger than the predicted resolution of 0.25 µm for the system. No condenser lens is used and the parabolic reflector in the flashlight housing serves to direct and shape light towards the sample.

The microscope was used to analyze smear samples from 19 patients suspected of having TB, an infectious disease that usually attacks the lungs and can be fatal if not treated. The TB smear samples came from Tehran, Iran, and they were tested in The Methodist Hospital Research Institute (TMHRI; Houston, TX, USA). Slides were stained with auramine orange and evaluated as being positive or negative for Mycobacterium tuberculosis with both the new portable fluorescence microscope and a laboratory-grade fluorescence microscope. Similar findings were obtained in 98.4% of the samples tested when compared with those from a standard reference microscope. M. tuberculosis bacilli could be clearly resolved at 400× magnification.

Rebecca Richards-Kortum, Ph.D., at Rice University (Houston, TX, USA), where the microscope was first constructed, said, "The microscope, which is portable, durable and inexpensive, could be used to diagnose tuberculosis in community or rural health centers with limited infrastructure in the developing world, promoting early detection and successful treatment of the disease.” The results of the study were published online in 2010 in PloS ONE.

Related Links:
The Methodist Hospital Research Institute



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Rheumatoid Factors (RF) Test
Rheumatoid Factors (RF)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.